DOI QR코드

DOI QR Code

Letter to the Editor Concerning "Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies"

  • Chappelle, Anne H. (International Isocyanate Institute, Inc.)
  • 발행 : 2022.03.30

초록

키워드

참고문헌

  1. Park RM. Risk assessment for toluene diisocyanate and respiratory disease human studies. Saf Health Work 2021;12(2):174-83. https://doi.org/10.1016/j.shaw.2020.12.002
  2. Le Moual N, Kauffmann F, Eisen EA, Kennedy SA. The healthy worker effect in asthma. Work may cause asthma, but asthma may also influence work. Am J Respir Crit Care Med 2008;177:4-10. https://doi.org/10.1164/rccm.200703-415PP
  3. Adams WG. Long-term effects on the health of men engaged in the manufacture of tolylene di-isocyanate. Br J Ind Med 1975;32(1):72-8.
  4. Bernstein DI. Occupational asthma. Clin Allergy 1992;76(4):917-34.
  5. Ott MG, Diller WF, Jolly AT. Respiratory effects of toluene diisocyanate in the workplace: a discussion of exposure-response relationships. Crit Rev Toxicol 2003;33(1):1-59. https://doi.org/10.1080/713611031
  6. Uppal N, Bhinder S, Ribeiro M, Chaudhry S, Stanbrook MB, Liss G, Tarlo SM. Prognosis of diisocyanate-induced occupational asthma: a systematic review. Am J Respir Crit Care Med 2016;193:A3705.
  7. Pauluhn J, Whalan JE. Human risk assessment of inhaled irritants: role of sensory stimulations from spatially separated nociceptors. Toxicology 2021;462:152929. https://doi.org/10.1016/j.tox.2021.152929
  8. Daniels RD. Occupational asthma risk from exposures to toluene diisocyanate: a review and risk assessment. Am J Ind Med 2018;61(4):282-92. https://doi.org/10.1002/ajim.22815
  9. Belin L, Wass U, Audunsson G, Mathiasson L. Amines: possible causative agents in the d development of bronchial hyperreactivity in workers manufacturing polyurethanes from isocyanates. Br J Ind Med 1983;40(3):251-7.
  10. Clark RL, Bugler J, McDermott M, Hill ID, Allport DC, Chamberlain JD. An epidemiology study of lung function changes of toluene diisocyanate foam workers in the United Kingdom. Int Arch Occup Environ Health 1998;71(3):169-79. https://doi.org/10.1007/s004200050267
  11. Plehiers PM, Chappelle AH, Spence MW. Practical learnings from an epidemiology study on TDI-related occupational asthma: Part I-cumulative exposure is not a good indicator of risk. Toxicol Ind Health 2020;36(11):876-84 (Supplemental Information - 4). https://doi.org/10.1177/0748233720947202
  12. Collins JJ, Anteau S, Conner PR, Cassidy LD, Doney B, Wang ML, Kurth L, Carson M, Molenaar D, Redlich CA, Storey E. Incidence of occupational asthma and exposure to toluene diisocyanate in the United States toluene diisocyanate production industry. J Occup Environ Med 2017;59:S22-7. https://doi.org/10.1097/jom.0000000000000890
  13. Wang ML, Storey E, Cassidy LD, Doney B, Conner PR, Collins JJ, Carson M, Molenaar D. Longitudinal and cross-sectional analyses of lung function in toluene diisocyanate production workers. J Occup Environ Med 2021;59(12S):S28-35.
  14. Bodner KM, Burns CJ, Randolph NM, Salazar EJ. A longitudinal study of respiratory health of toluene diisocyanate production workers. J Occup Environ Med 2001;43(10):890-7. https://doi.org/10.1097/00043764-200110000-00008
  15. Mikoczy Z, Welinder H, Tinnerberg H, Hagmar L. Cancer incidence and mortality of isocyanate exposed workers from the Swedish polyurethane foam industry: updated findings 1959-98. Occup Environ Med 2004;61(5):432-7. https://doi.org/10.1136/oem.2003.009712
  16. Sorahan T, Nichols L. Mortality and cancer morbidity of production workers in the UK flexible polyurethane foam industry: updated findings, 1958-98. Occup Environ Med 2002;59(11):751-8. https://doi.org/10.1136/oem.59.11.751
  17. Pinkerton LE, Yiin JH, Daniels RD, Fent KW. Mortality among workers exposed to toluene diisocyanate in the US polyurethane foam industry: update and exposure-response analyses. Am J Ind Med 2016;59:630-43. https://doi.org/10.1002/ajim.22622